Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Fair Isaac Corporation is a software-application business based in the US. Fair Isaac Corporation shares (FICO) are listed on the NYSE and all prices are listed in US Dollars. Fair Isaac Corporation employs 3,460 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $408.26 |
|---|---|
| 52-week range | $340.48 - $553.97 |
| 50-day moving average | $387.81 |
| 200-day moving average | $420.74 |
| Wall St. target price | $500.29 |
| PE ratio | 27.7917 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $14.69 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $408.26 from 2022-07-01
| 1 week (2022-06-28) | 1.72% |
|---|---|
| 1 month (2022-06-02) | N/A |
| 3 months (2022-04-04) | -9.76% |
| 6 months (2022-01-06) | -7.95% |
| 1 year (2021-07-06) | -20.99% |
|---|---|
| 2 years (2020-07-06) | -2.06% |
| 3 years (2019-07-05) | 22.81% |
| 5 years (2017-07-05) | 193.88% |
Valuing Fair Isaac Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fair Isaac Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fair Isaac Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Fair Isaac Corporation shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Fair Isaac Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.71. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fair Isaac Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fair Isaac Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $514.3 million.
The EBITDA is a measure of a Fair Isaac Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.4 billion |
|---|---|
| Operating margin TTM | 36.41% |
| Gross profit TTM | $984.1 million |
| Return on assets TTM | 20.07% |
| Return on equity TTM | 35.62% |
| Profit margin | 31.52% |
| Book value | $11.09 |
| Market capitalisation | $10.6 billion |
TTM: trailing 12 months
We're not expecting Fair Isaac Corporation to pay a dividend over the next 12 months.
Fair Isaac Corporation's shares were split on a 3:2 basis on 10 March 2004. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Fair Isaac Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Fair Isaac Corporation shares which in turn could have impacted Fair Isaac Corporation's share price.
Over the last 12 months, Fair Isaac Corporation's shares have ranged in value from as little as $340.48 up to $553.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Fair Isaac Corporation's is 1.2468. This would suggest that Fair Isaac Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Fair Isaac Corporation develops analytic, software, and data management products and services that enable businesses to automate, enhance, and connect decisions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Scores and Software. The Software segment offers pre-configured decision management solution designed for various business problems or processes, such as marketing, account origination, customer management, customer engagement, fraud detection, financial crimes compliance, collection, and marketing, as well as associated professional services. This segment also provides FICO Platform, a modular software offering designed to support advanced analytic and decision use cases, as well as stand-alone analytic and decisioning software that can be configured by customers to address a wide range of business use cases. The Scores segment provides business-to-business scoring solutions and services for consumers that give clients access to analytics to be integrated into their transaction streams and decision-making processes, as well as business-to-consumer scoring solutions comprising myFICO. com subscription offerings. Fair Isaac Corporation markets its products and services primarily through its direct sales organization and indirect channels, as well as online.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.